首页 | 官方网站   微博 | 高级检索  
     


Activation of Nrf2/HO-1 by Peptide YD1 Attenuates Inflammatory Symptoms through Suppression of TLR4/MYyD88/NF-κB Signaling Cascade
Authors:Md Saifur Rahman  Md Badrul Alam  Young Kyun Kim  Mst Hur Madina  Ismail Fliss  Sang Han Lee  Jin Cheol Yoo
Affiliation:1.Department of Pharmacy, College of Pharmacy, Chosun University, Gwangju 501-759, Korea; (M.S.R.); (Y.K.K.);2.Department of Food Science, Faculty of Agriculture and Food Sciences, Laval University, Québec, QC G1V 0A6, Canada;3.Department of Food Science and Biotechnology, Kyungpook National University, Daegu 702-701, Korea;4.Department of Phytology, Faculty of Agriculture and Food Sciences, Laval University, Québec, QC G1V 0A6, Canada;
Abstract:In this study, we investigate the immunomodulatory effects of a novel antimicrobial peptide, YD1, isolated from Kimchi, in both in vitro and in vivo models. We establish that YD1 exerts its anti-inflammatory effects via up-regulation of the Nrf2 pathway, resulting in the production of HO-1, which suppresses activation of the NF-κB pathway, including the subsequent proinflammatory cytokines IL-1β, IL-6, and TNF-α. We also found that YD1 robustly suppresses nitric oxide (NO) and prostaglandin E2 (PGE2) production by down-regulating the expression of the upstream genes, iNOS and COX-2, acting as a strong antioxidant. Collectively, YD1 exhibits vigorous anti-inflammatory and antioxidant activity, presenting it as an interesting potential therapeutic agent.
Keywords:anti-inflammation  YD1  peptide drug  NF-κ  B  RAW 264  7  TLR-4  MyD88  AKT
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号